Bertrand Billemont

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

Gabriel G. Malouf, Philippe Camparo, Stéphane Oudard et al. · Annals of Oncology · 2010 · 223 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Systemic mastocytosis and bone involvement in a cohort of 75 patients

Stéphane Barète, Noémie Assous, C. De Gennes et al. · Annals of the Rheumatic Diseases · 2010 · 159 citations

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 118 citations

Sorafenib Determination, Oncology, Cancer Detection +11

Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis

Pascaline Boudou‐Rouquette, Stanislas Ropert, Olivier Mir et al. · The Oncologist · 2012 · 104 citations · Full text